VERACYTE INC (VCYT) Fundamental Analysis & Valuation
NASDAQ:VCYT • US92337F1075
Current stock price
32.78 USD
-0.5 (-1.5%)
At close:
32.78 USD
0 (0%)
After Hours:
This VCYT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. VCYT Profitability Analysis
1.1 Basic Checks
- VCYT had positive earnings in the past year.
- VCYT had a positive operating cash flow in the past year.
- In multiple years VCYT reported negative net income over the last 5 years.
- Of the past 5 years VCYT 4 years had a positive operating cash flow.
1.2 Ratios
- VCYT's Return On Assets of 4.72% is amongst the best of the industry. VCYT outperforms 90.93% of its industry peers.
- VCYT's Return On Equity of 5.07% is amongst the best of the industry. VCYT outperforms 90.35% of its industry peers.
- The Return On Invested Capital of VCYT (4.59%) is better than 90.73% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.72% | ||
| ROE | 5.07% | ||
| ROIC | 4.59% |
ROA(3y)-0.03%
ROA(5y)-1.93%
ROE(3y)0%
ROE(5y)-2.06%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- VCYT's Profit Margin of 12.83% is amongst the best of the industry. VCYT outperforms 91.70% of its industry peers.
- Looking at the Operating Margin, with a value of 15.14%, VCYT belongs to the top of the industry, outperforming 92.08% of the companies in the same industry.
- VCYT has a Gross Margin of 70.10%. This is amongst the best in the industry. VCYT outperforms 80.89% of its industry peers.
- In the last couple of years the Gross Margin of VCYT has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.14% | ||
| PM (TTM) | 12.83% | ||
| GM | 70.1% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.15%
GM growth 5Y1.62%
2. VCYT Health Analysis
2.1 Basic Checks
- VCYT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- Compared to 1 year ago, VCYT has more shares outstanding
- VCYT has more shares outstanding than it did 5 years ago.
- VCYT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- An Altman-Z score of 16.99 indicates that VCYT is not in any danger for bankruptcy at the moment.
- The Altman-Z score of VCYT (16.99) is better than 87.84% of its industry peers.
- There is no outstanding debt for VCYT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 16.99 |
ROIC/WACC0.52
WACC8.9%
2.3 Liquidity
- A Current Ratio of 8.15 indicates that VCYT has no problem at all paying its short term obligations.
- Looking at the Current ratio, with a value of 8.15, VCYT is in the better half of the industry, outperforming 73.55% of the companies in the same industry.
- VCYT has a Quick Ratio of 7.81. This indicates that VCYT is financially healthy and has no problem in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 7.81, VCYT is in the better half of the industry, outperforming 72.20% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 8.15 | ||
| Quick Ratio | 7.81 |
3. VCYT Growth Analysis
3.1 Past
- VCYT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 176.67%, which is quite impressive.
- The Revenue has grown by 16.01% in the past year. This is quite good.
- The Revenue has been growing by 34.50% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)176.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%750%
Revenue 1Y (TTM)16.01%
Revenue growth 3Y20.37%
Revenue growth 5Y34.5%
Sales Q2Q%18.55%
3.2 Future
- VCYT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.22% yearly.
- VCYT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.74% yearly.
EPS Next Y39.38%
EPS Next 2Y26.95%
EPS Next 3Y26.37%
EPS Next 5Y21.22%
Revenue Next Year12.64%
Revenue Next 2Y12.58%
Revenue Next 3Y12.06%
Revenue Next 5Y10.74%
3.3 Evolution
- The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. VCYT Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 39.49, which means the current valuation is very expensive for VCYT.
- Based on the Price/Earnings ratio, VCYT is valued cheaper than 90.93% of the companies in the same industry.
- VCYT is valuated expensively when we compare the Price/Earnings ratio to 25.73, which is the current average of the S&P500 Index.
- VCYT is valuated quite expensively with a Price/Forward Earnings ratio of 28.34.
- 92.66% of the companies in the same industry are more expensive than VCYT, based on the Price/Forward Earnings ratio.
- VCYT's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 23.72.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 39.49 | ||
| Fwd PE | 28.34 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, VCYT is valued cheaply inside the industry as 92.66% of the companies are valued more expensively.
- 95.56% of the companies in the same industry are more expensive than VCYT, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.57 | ||
| EV/EBITDA | 21.88 |
4.3 Compensation for Growth
- The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- The decent profitability rating of VCYT may justify a higher PE ratio.
- VCYT's earnings are expected to grow with 26.37% in the coming years. This may justify a more expensive valuation.
PEG (NY)1
PEG (5Y)N/A
EPS Next 2Y26.95%
EPS Next 3Y26.37%
5. VCYT Dividend Analysis
5.1 Amount
- VCYT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
VCYT Fundamentals: All Metrics, Ratios and Statistics
32.78
-0.5 (-1.5%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-25 2026-02-25/amc
Earnings (Next)05-05 2026-05-05/amc
Inst Owners110.45%
Inst Owner Change-4.94%
Ins Owners0.42%
Ins Owner Change6.05%
Market Cap2.60B
Revenue(TTM)517.14M
Net Income(TTM)66.35M
Analysts82.11
Price Target50.17 (53.05%)
Short Float %6.96%
Short Ratio6.32
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)105.79%
Min EPS beat(2)79.03%
Max EPS beat(2)132.56%
EPS beat(4)3
Avg EPS beat(4)43.36%
Min EPS beat(4)-110.32%
Max EPS beat(4)132.56%
EPS beat(8)6
Avg EPS beat(8)164.25%
EPS beat(12)8
Avg EPS beat(12)72.71%
EPS beat(16)12
Avg EPS beat(16)65.75%
Revenue beat(2)2
Avg Revenue beat(2)3.25%
Min Revenue beat(2)3.19%
Max Revenue beat(2)3.31%
Revenue beat(4)4
Avg Revenue beat(4)3.32%
Min Revenue beat(4)1.01%
Max Revenue beat(4)5.76%
Revenue beat(8)7
Avg Revenue beat(8)3.84%
Revenue beat(12)11
Avg Revenue beat(12)4.44%
Revenue beat(16)15
Avg Revenue beat(16)5.09%
PT rev (1m)0.93%
PT rev (3m)1.69%
EPS NQ rev (1m)-10%
EPS NQ rev (3m)-22.76%
EPS NY rev (1m)2.37%
EPS NY rev (3m)10.57%
Revenue NQ rev (1m)0.46%
Revenue NQ rev (3m)0.29%
Revenue NY rev (1m)1.2%
Revenue NY rev (3m)2.33%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 39.49 | ||
| Fwd PE | 28.34 | ||
| P/S | 5.04 | ||
| P/FCF | 20.57 | ||
| P/OCF | 19.11 | ||
| P/B | 1.99 | ||
| P/tB | 5.75 | ||
| EV/EBITDA | 21.88 |
EPS(TTM)0.83
EY2.53%
EPS(NY)1.16
Fwd EY3.53%
FCF(TTM)1.59
FCFY4.86%
OCF(TTM)1.72
OCFY5.23%
SpS6.51
BVpS16.48
TBVpS5.7
PEG (NY)1
PEG (5Y)N/A
Graham Number17.54
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.72% | ||
| ROE | 5.07% | ||
| ROCE | 5.82% | ||
| ROIC | 4.59% | ||
| ROICexc | 6.63% | ||
| ROICexgc | 80.43% | ||
| OM | 15.14% | ||
| PM (TTM) | 12.83% | ||
| GM | 70.1% | ||
| FCFM | 24.49% |
ROA(3y)-0.03%
ROA(5y)-1.93%
ROE(3y)0%
ROE(5y)-2.06%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.15%
GM growth 5Y1.62%
F-Score8
Asset Turnover0.37
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 45.19% | ||
| Cap/Sales | 1.87% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 136.72% | ||
| Profit Quality | 190.84% | ||
| Current Ratio | 8.15 | ||
| Quick Ratio | 7.81 | ||
| Altman-Z | 16.99 |
F-Score8
WACC8.9%
ROIC/WACC0.52
Cap/Depr(3y)43.31%
Cap/Depr(5y)38.08%
Cap/Sales(3y)2.39%
Cap/Sales(5y)2.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)176.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%750%
EPS Next Y39.38%
EPS Next 2Y26.95%
EPS Next 3Y26.37%
EPS Next 5Y21.22%
Revenue 1Y (TTM)16.01%
Revenue growth 3Y20.37%
Revenue growth 5Y34.5%
Sales Q2Q%18.55%
Revenue Next Year12.64%
Revenue Next 2Y12.58%
Revenue Next 3Y12.06%
Revenue Next 5Y10.74%
EBIT growth 1Y301.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year205.84%
EBIT Next 3Y58.94%
EBIT Next 5Y37.52%
FCF growth 1Y98.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y81.51%
OCF growth 3Y162.45%
OCF growth 5YN/A
VERACYTE INC / VCYT Fundamental Analysis FAQ
What is the fundamental rating for VCYT stock?
ChartMill assigns a fundamental rating of 7 / 10 to VCYT.
What is the valuation status of VERACYTE INC (VCYT) stock?
ChartMill assigns a valuation rating of 6 / 10 to VERACYTE INC (VCYT). This can be considered as Fairly Valued.
How profitable is VERACYTE INC (VCYT) stock?
VERACYTE INC (VCYT) has a profitability rating of 7 / 10.
Can you provide the PE and PB ratios for VCYT stock?
The Price/Earnings (PE) ratio for VERACYTE INC (VCYT) is 39.49 and the Price/Book (PB) ratio is 1.99.
What is the financial health of VERACYTE INC (VCYT) stock?
The financial health rating of VERACYTE INC (VCYT) is 8 / 10.